ArticleCEN case reports2017

Tubulointerstitial nephritis as adverse effect of programmed cell death 1 inhibitor, nivolumab, showed distinct histological findings.

Ai Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.